Extracellular Vesicles in Liver Diseases: Meeting Report from the International Liver Congress 2018

Overview

Journal Hepatol Commun

Specialty Gastroenterology

Date 2019 Feb 16

PMID 30766966

Citations 10

Authors

Jesus M Banales

Ariel E Feldstein

Hanna Sanger

Veronika Lukacs-Kornek

Gyongyi Szabo

Miroslaw Kornek

Affiliations

Soon will be listed here.

Abstract

Extracellular vesicles (EVs) are small and heterogeneous membrane-bound structures released by cells and found in all biological fluids. They are effective intercellular communicators, acting on a number of close and/or distant target cells. EV cargo may reflect the cell of origin as well as the specific stress that induces their formation and release. They transport a variety of bioactive molecules, including messenger RNA, noncoding RNAs, proteins, lipids, and metabolites, that can be transferred among cells, regulating various cell responses. Alteration in the concentration and composition of EVs in biological fluids is a typical hallmark of pathologies in different liver diseases. Circulating EVs can serve as biomarkers or as messengers following uptake by other cells. This review is a meeting report from the International Liver Congress 2018 (European Association for the Study of the Liver) celebrated in Paris (Symposium: Extracellular vesicles and signal transmission) that discusses the role of EVs in several liver diseases, highlighting their potential value as disease biomarkers and therapeutic opportunities.

Citing Articles

Hepatocellular carcinoma extracellular vesicle ECG score as a diagnostic tool close to the ideal.

Slomka A, Mocan T, Willms A, Lukacs-Kornek V, Kornek M Hepatobiliary Surg Nutr. 2023; 12(6):930-932.

PMID: 38115928 PMC: 10727809. DOI: 10.21037/hbsn-23-509.

Extracellular Vesicles and Circulating Tumour Cells - complementary liquid biopsies or standalone concepts?.

Slomka A, Wang B, Mocan T, Horhat A, Willms A, Schmidt-Wolf I Theranostics. 2022; 12(13):5836-5855.

PMID: 35966579 PMC: 9373826. DOI: 10.7150/thno.73400.

Alcohol-Associated Tissue Injury: Current Views on Pathophysiological Mechanisms.

Simon L, Souza-Smith F, Molina P Annu Rev Physiol. 2022; 84:87-112.

PMID: 35143331 PMC: 11268381. DOI: 10.1146/annurev-physiol-060821-014008.

Liquid Biopsy in Hepatocellular Carcinoma: Where Are We Now?.

Pelizzaro F, Cardin R, Penzo B, Pinto E, Vitale A, Cillo U Cancers (Basel). 2021; 13(9).

PMID: 34068786 PMC: 8126224. DOI: 10.3390/cancers13092274.

Circulating microRNA‑135a‑3p in serum extracellular vesicles as a potential biological marker of non‑alcoholic fatty liver disease.

Jiang H, Qian Y, Shen Z, Liu Y, He Y, Gao R Mol Med Rep. 2021; 24(1).

PMID: 33955511 PMC: 8127071. DOI: 10.3892/mmr.2021.12137.

References

Thery C, Zitvogel L, Amigorena S . Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002; 2(8):569-79. DOI: 10.1038/nri855. View

Hazra S, Xiong S, Wang J, Rippe R, Krishna V, Chatterjee K . Peroxisome proliferator-activated receptor gamma induces a phenotypic switch from activated to quiescent hepatic stellate cells. J Biol Chem. 2004; 279(12):11392-401. DOI: 10.1074/jbc.M310284200. View

Hristov M, Erl W, Linder S, Weber P . Apoptotic bodies from endothelial cells enhance the number and initiate the differentiation of human endothelial progenitor cells in vitro. Blood. 2004; 104(9):2761-6. DOI: 10.1182/blood-2003-10-3614. View

Marzesco A, Janich P, Wilsch-Brauninger M, Dubreuil V, Langenfeld K, Corbeil D . Release of extracellular membrane particles carrying the stem cell marker prominin-1 (CD133) from neural progenitors and other epithelial cells. J Cell Sci. 2005; 118(Pt 13):2849-58. DOI: 10.1242/jcs.02439. View

Cheung O, Puri P, Eicken C, Contos M, Mirshahi F, Maher J . Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression. Hepatology. 2008; 48(6):1810-20. PMC: 2717729. DOI: 10.1002/hep.22569. View

Thery C, Ostrowski M, Segura E . Membrane vesicles as conveyors of immune responses. Nat Rev Immunol. 2009; 9(8):581-93. DOI: 10.1038/nri2567. View

Zhu H, Wu H, Liu X, Li B, Chen Y, Ren X . Regulation of autophagy by a beclin 1-targeted microRNA, miR-30a, in cancer cells. Autophagy. 2009; 5(6):816-23. PMC: 3669137. DOI: 10.4161/auto.9064. View

Chargaff E, West R . The biological significance of the thromboplastic protein of blood. J Biol Chem. 2010; 166(1):189-97. View

Masyuk A, Huang B, Ward C, Gradilone S, Banales J, Masyuk T . Biliary exosomes influence cholangiocyte regulatory mechanisms and proliferation through interaction with primary cilia. Am J Physiol Gastrointest Liver Physiol. 2010; 299(4):G990-9. PMC: 2957333. DOI: 10.1152/ajpgi.00093.2010. View

10.

Mause S, Weber C . Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ Res. 2010; 107(9):1047-57. DOI: 10.1161/CIRCRESAHA.110.226456. View

11.

Hurley J, Boura E, Carlson L, Rozycki B . Membrane budding. Cell. 2010; 143(6):875-87. PMC: 3102176. DOI: 10.1016/j.cell.2010.11.030. View

12.

Gyorgy B, Szabo T, Pasztoi M, Pal Z, Misjak P, Aradi B . Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci. 2011; 68(16):2667-88. PMC: 3142546. DOI: 10.1007/s00018-011-0689-3. View

13.

Rautou P, Bresson J, Sainte-Marie Y, Vion A, Paradis V, Renard J . Abnormal plasma microparticles impair vasoconstrictor responses in patients with cirrhosis. Gastroenterology. 2012; 143(1):166-76.e6. DOI: 10.1053/j.gastro.2012.03.040. View

14.

Kornek M, Lynch M, Mehta S, Lai M, Exley M, Afdhal N . Circulating microparticles as disease-specific biomarkers of severity of inflammation in patients with hepatitis C or nonalcoholic steatohepatitis. Gastroenterology. 2012; 143(2):448-58. PMC: 3404266. DOI: 10.1053/j.gastro.2012.04.031. View

15.

Kornek M, Schuppan D . Microparticles: Modulators and biomarkers of liver disease. J Hepatol. 2012; 57(5):1144-6. DOI: 10.1016/j.jhep.2012.07.029. View

16.

Schmelzle M, Splith K, Andersen L, Kornek M, Schuppan D, Jones-Bamman C . Increased plasma levels of microparticles expressing CD39 and CD133 in acute liver injury. Transplantation. 2012; 95(1):63-9. PMC: 3536489. DOI: 10.1097/TP.0b013e318278d3cd. View

17.

Szabo G, Bala S . MicroRNAs in liver disease. Nat Rev Gastroenterol Hepatol. 2013; 10(9):542-52. PMC: 4091636. DOI: 10.1038/nrgastro.2013.87. View

18.

Povero D, Eguchi A, Niesman I, Andronikou N, de Mollerat du Jeu X, Mulya A . Lipid-induced toxicity stimulates hepatocytes to release angiogenic microparticles that require Vanin-1 for uptake by endothelial cells. Sci Signal. 2013; 6(296):ra88. PMC: 4016801. DOI: 10.1126/scisignal.2004512. View

19.

Li L, Masica D, Ishida M, Tomuleasa C, Umegaki S, Kalloo A . Human bile contains microRNA-laden extracellular vesicles that can be used for cholangiocarcinoma diagnosis. Hepatology. 2014; 60(3):896-907. PMC: 4121391. DOI: 10.1002/hep.27050. View

20.

Momen-Heravi F, Bala S, Bukong T, Szabo G . Exosome-mediated delivery of functionally active miRNA-155 inhibitor to macrophages. Nanomedicine. 2014; 10(7):1517-27. PMC: 4180003. DOI: 10.1016/j.nano.2014.03.014. View